Pricing Log in Create free account

Celcuity, Inc. (CELC) vs Enliven Therapeutics, Inc. (ELVN)

Celcuity, Inc. and Enliven Therapeutics, Inc. are both Biotechnology companies. Celcuity, Inc. and Enliven Therapeutics, Inc. are of similar size ($3.3B and $3.1B). Across the 8 metrics below, Enliven Therapeutics, Inc. leads on 6 and Celcuity, Inc. on 2.

Valuation

Metric CELC ELVN Biotechnology median
P/E n/m n/m 10.26
P/S n/m n/m 9.18
P/B n/m 3.34 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA n/m n/m 0.65
EV/Sales n/m n/m 8.98
Earnings yield (6.66%) (3.69%) (34.89%)
Free cash flow yield (5.43%) (2.24%) (24.52%)

Profitability

Metric CELC ELVN Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (1,433.70%) (15.31%) (50.12%)
Return on assets (44.77%) (14.98%) (45.60%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CELC ELVN Biotechnology median
Revenue growth (TTM) — — 6.26%
EPS growth (last fiscal year) (33.92%) 3.17% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CELC ELVN Biotechnology median
Debt to equity (58.93) 0.00 0.00
Current ratio 8.93 64.07 4.89
Net debt to EBITDA 0.71 3.87 1.01

Dividend

Metric CELC ELVN Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CELC ELVN Biotechnology median
Market cap 3.13b 3.28b 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack